TOLLIP
Basic information
Region (hg38): 11:1274371-1309654
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOLLIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 1 |
Variants in TOLLIP
This is a list of pathogenic ClinVar variants found in the TOLLIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-1277074-T-C | Benign (May 31, 2018) | |||
11-1277077-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
11-1277085-T-C | not specified | Likely benign (Dec 21, 2023) | ||
11-1277153-G-C | not specified | Uncertain significance (Jul 27, 2021) | ||
11-1277191-C-A | not specified | Uncertain significance (Jan 26, 2022) | ||
11-1277197-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
11-1286023-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
11-1286056-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
11-1286077-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
11-1288625-G-A | not specified | Uncertain significance (May 21, 2024) | ||
11-1288638-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
11-1288694-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
11-1288703-A-T | not specified | Uncertain significance (Mar 07, 2024) | ||
11-1288704-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
11-1290264-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
11-1290298-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
11-1290340-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
11-1290342-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
11-1290360-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
11-1291476-C-G | Interstitial lung disease 2 • Chronic obstructive pulmonary disease • Combined pulmonary fibrosis-emphysema syndrome | Uncertain significance; association (May 04, 2021) | ||
11-1295674-C-T | not specified | Uncertain significance (May 29, 2024) | ||
11-1295682-A-T | not specified | Uncertain significance (Apr 22, 2022) | ||
11-1295760-C-A | not specified | Uncertain significance (Mar 20, 2023) | ||
11-1304599-T-C | Chronic obstructive pulmonary disease • Interstitial lung disease 2 | Uncertain significance (May 04, 2021) | ||
11-1309467-G-C | not specified | Uncertain significance (Jan 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOLLIP | protein_coding | protein_coding | ENST00000317204 | 6 | 35284 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0811 | 0.910 | 125678 | 0 | 10 | 125688 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.12 | 142 | 185 | 0.769 | 0.0000126 | 1776 |
Missense in Polyphen | 40 | 68.346 | 0.58526 | 600 | ||
Synonymous | 0.429 | 77 | 81.9 | 0.940 | 0.00000647 | 542 |
Loss of Function | 2.27 | 4 | 12.7 | 0.314 | 6.32e-7 | 133 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000124 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000554 | 0.0000544 |
Finnish | 0.0000937 | 0.0000924 |
European (Non-Finnish) | 0.0000457 | 0.0000440 |
Middle Eastern | 0.0000554 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the signaling pathway of IL-1 and Toll-like receptors. Inhibits cell activation by microbial products. Recruits IRAK1 to the IL-1 receptor complex. Inhibits IRAK1 phosphorylation and kinase activity (PubMed:11751856). Connects the ubiquitin pathway to autophagy by functioning as a ubiquitin- ATG8 family adapter and thus mediating autophagic clearance of ubiquitin conjugates. The TOLLIP-dependent selective autophagy pathway plays an important role in clearance of cytotoxic polyQ proteins aggregates (PubMed:25042851). {ECO:0000269|PubMed:11751856, ECO:0000269|PubMed:25042851}.;
- Pathway
- Toll-like receptor signaling pathway - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Apoptosis Modulation and Signaling;IL-1 signaling pathway;Structural Pathway of Interleukin 1 (IL-1);Toll-like Receptor Signaling;Toll-like Receptor Signaling Pathway;TLR NFkB;Neutrophil degranulation;Signaling by Interleukins;signal transduction through il1r;toll-like receptor pathway;Cytokine Signaling in Immune system;Interleukin-1 signaling;Innate Immune System;Immune System;inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;IL-1 NFkB;IL-1 p38;IL-1 JNK;IL1;TLR p38;EGFR1;TLR ECSIT MEKK1 JNK;TLR ECSIT MEKK1 p38;TLR JNK;IL1-mediated signaling events;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.200
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.43
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- Y
- hipred_score
- 0.801
- ghis
- 0.575
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.792
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tollip
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- tollip
- Affected structure
- caudal fin
- Phenotype tag
- abnormal
- Phenotype quality
- curved
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;autophagy;inflammatory response;signal transduction;cell-cell signaling;phosphorylation;epithelial cell differentiation;positive regulation of protein sumoylation;intracellular signal transduction;protein localization to endosome;neutrophil degranulation;innate immune response;leukocyte activation;interleukin-1-mediated signaling pathway
- Cellular component
- extracellular region;cytoplasm;cytosol;nuclear body;azurophil granule lumen;specific granule lumen;interleukin-18 receptor complex;interleukin-1 receptor complex;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- interleukin-1, type I receptor binding;protein binding;kinase binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase binding;SUMO binding;Toll-like receptor binding;ubiquitin binding